Contract Pharmaceuticals Limited Canada is recalling approximately 11,350 bottles of Clindamycin Phosphate Topical Solution (1%), a prescription antibiotic used for acne. The 60 mL bottles are being recalled because the containers are defective and may experience slow leakage under the cap. No incidents or injuries have been reported in connection with this defect.
The defective caps allow the liquid medication to leak out of the bottle, which may result in a loss of product or potential skin contact with the solution in unintended areas.
You have 2 options:
Recall #: D-1139-2023; Manufactured for Glasshouse Pharmaceuticals Limited Canada.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.